11/06/2025
Discover how genetic testing is revolutionizing breast and gynecological cancer care—from risk assessment to survivorship. Join us for an insightful webinar featuring real patient stories, practical tools like the MyRisk® Hereditary Cancer Test with RiskScore®, and the power of research through the Myriad Collaborative Research Registry™ (MCRR).
10/28/2025
Be among the first to explore the upcoming enhancements to the MyRisk® Hereditary Cancer Test. This session will unveil expanded gene coverage, including 15 newly added guideline-recommended genes and 36 evidence-based intronic variants. Our clinical experts will discuss the associated cancer risks and how these updates empower healthcare providers to deliver more personalized risk assessments and confidently guide patient management.
From Theory to Practice: Incorporating Polygenic Risk Scores in Breast Cancer Risk Assessment
Date:
12/03/2025
Time:
1 PM EST
Duration:
1 hour
Speakers:
CEU:
Yes
How Cancer Care Northwest Made Germline Genetic Testing Routine In Oncology
11/20/2025
No
Genetics & Family Ties: The Power of Testing for Lynch Syndrome
11/18/2025
Beyond Diagnosis: Transforming Care with Genetic Insights
Elevating High-Risk Breast Cancer Care: The Impact of MyRisk® Hereditary Cancer Test with RiskScore®
10/30/2025
Impact of Breast Cancer Risk Prediction on Personalized Screening
10/29/2025
Exclusive Premier! Expanding the MyRisk® Hereditary Cancer Test Panel: More Genes, More Answers
Navigating hereditary cancer guidelines for emerging genes
10/21/2025
Turning Insights into Impact: A Guide to Breast Cancer Risk Assessment
10/16/2025
Quarterly Molecular Tumor Board: Review targeted therapies and management options for breast cancer patients
09/30/2025
Combining genetic and genomic testing in ovarian cancer through multidisciplinary collaboration
09/24/2025
Guiding Golden Years: How Providers use the GeneSight test to Illuminate and Improve Treatment Outcomes in Patients 65+
08/05/2025
Breaking Barriers Together: Creative Approaches to Genetic Services in Oncology
07/30/2025
Quarterly Molecular Tumor Board: Review targeted therapies and management options for gynecologic cancer patients.
07/22/2025
Big Data, Little Data: Utilizing research registries to foster collaboration in cancer genetics and impact patient care
05/20/2025
Explore targeted therapies and management options for gastrointestinal cancer patients based on germline and genomic findings.
05/15/2025
The GeneSight Advantage: Leading the Way in Mental Health PGx
04/29/2025
Maternal Malignancy Detection Through pcfDNA Screening
04/23/2025
Enhancing Variant Interpretation Through RNA Analysis
10/23/2024
From Genes to Treatment: Real-World Evidence with GeneSight Case Studies
10/15/2024
Guidelines and Clinical Applications of Germline and Somatic Variant Classification
10/08/2024
Continue Going Beyond Green, Yellow, Red on the GeneSight® Report
06/11/2024
Part 3 - Hot Topics in Breast Cancer Genetic Testing
05/22/2024
Integrating genetic insights to guide personalized surgical decision making and high-risk management
04/12/2024
APC: The Tour of Time
03/27/2024
Going Beyond Green, Yellow, Red on the GeneSight® Report
03/19/2024
Updates to Cancer Risk and Clinical Guidance for Germline Variation in CHEK2
02/27/2024
Part 2 - Breast Cancer Risk Assessment and High-Risk Management
02/15/2024
Part 1 - Foundations and Application of Germline Testing
11/30/2023